Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Aclaris Therapts Cmn

TRADE

NASDAQ: ACRSHealthcare / Biotechnology / USA
15.65-0.15-0.95%Vol 169 4341Y Perf -38.04%
Aug 17th, 2018 16:00
BID15.65 ASK15.67
Open15.80 Previous Close15.80
Pre-Market- After-Trading15.65
 - -%  - -%
Target Price
47.00 
Analyst Rating
Strong Buy 1.00
Potencial %
200.32 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/11/11 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/43/43 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/52/52 
Income Ranking
 —    -
Market Cap (mil)485 
Earnings Rating
Price Range Ratio 52wk %
4.18 
Earnings Date

Today's Price Range

15.4315.95

 

52wk Range

15.0728.93

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-21.39%
3 Months
-19.55%
6 Months
-21.51%
1 Year
-38.04%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACRS15.65-0.1500-0.95
AAPL217.584.26002.00
GOOG1 200.96-5.5300-0.46
MSFT107.58-0.0600-0.06
XOM78.260.26000.33
WFC58.860.20000.34
JNJ134.471.99001.50
FB173.80-0.9000-0.52
GE12.300.00000.00
JPM114.770.00000.00
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 8.30
Current Ratio 8.50
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin48.20
EBIT Margin-1 653.90
EBITDA Margin-1 641.00
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.08
PS Ratios 97.86
Price to Cash Flow -
Price to Free Cash Flow -6.20
Cash Flow Per Share -2.49
Price to Tangible Book3.61
Book Value per Share5.62
Enterprise Value (in ths.)371 913
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-34.39
ROE last 12 Months -59.92
Return on Assets (5Y Avg) -16.62
ROA last 12 Months -54.18
Return on Capital (5Y Avg) -
ROC last 12 Months -59.73
Return on invested Capital Q -16.63
Return on invested Capital Y-34.69
Assets Turnover0.00
Receivables Turnover5.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)5 477
Revenue per Share 0.18
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.95-1.01-6.32
Q01 2018-0.99-0.981.01
Q04 2017-0.90-0.8011.11
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Q01 2017-0.54-0.4811.11
Q04 2016-0.59-0.4916.95
Q03 2016-0.68-0.5026.47
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.9578.26Positive
9/2018 QR-1.1160.22Positive
12/2018 FY-4.36--
12/2019 FY-3.39--
Next Report Date14th Aug 2018
Estimated EPS Next Report-0.95
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume169 434
Shares Outstanding (in ths.)30 980
Trades Count830
Dollar Volume2 325 097
Avg. Volume269 941
Avg. Weekly Volume175 187
Avg. Monthly Volume236 612
Avg. Quarterly Volume242 647

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

34%66%

Bearish Bullish

64%36%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x